Gujarat Terce Laboratories Q2 Results

  • BSE: 524314
  • NSE: -
  • ISIN: INE499G01013
  • Sector: Biotechnology & Drugs
BSE
75.88-1.54 (-1.99%)
Volume2.50 K
Updated: Tue 26 Nov, 2024 | 15:15:00
NSE
This stock is not traded on NSE
Today: 75.88
76.00
52-Wk: 25.84
94.90

Q2 Results Highlights

  • Total Income
    ₹13.30 Cr.
    (11.88%)
  • Operating Profit
    ₹1.57 Cr.
    (NA%)
  • Profit After Tax
    ₹1.48 Cr.
    (NA%)
  • Operating Margin
    11.78%
    (214.22%)
Note: Comparison is on YoY basis

Quarterly - Gujarat Terce Laboratories Q2 Results

*All figures in crores except per share values
Fiscal PeriodSep 24Jun 23QoQ CompSep 23YoY Comp
Total Revenue 13.3010.72-%12.03-%
Selling/ General/ Admin Expenses Total 4.21--%--%
Depreciation/ Amortization 0.090.09-%0.09-%
Other Operating Expenses Total 3.222.57-%2.07-%
Total Operating Expense 11.7311.94-%11.58-%
Operating Income 1.57-1.22-%0.45-%
Net Income Before Taxes 1.51-1.31-%0.33-%
Net Income 1.48-1.31-%0.33-%
Diluted Normalized EPS 2.00-1.76-%0.45-%

Recommended For You

    More Recommendations

    Trending Stocks

      Subscribe to Our Newsletter

      Get daily newsletters around different themes from livemint.

      Subscribe
      HomeMarketsPremiumInstant LoanMint Shorts